Provention Bio
PRVB
#4383
Rank
HK$18.48 B
Marketcap
HK$194.41
Share price
0.00%
Change (1 day)
528.83%
Change (1 year)

Revenue for Provention Bio (PRVB)

Revenue in 2022 (TTM): HK$0.10 Billion

According to Provention Bio's latest financial reports the company's current revenue (TTM ) is HK$0.10 Billion. In 2021 the company made a revenue of HK$10.87 Million an increase over the revenue in the year 2020 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Provention Bio from 2017 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) HK$0.10 B826.83%
2021 HK$10.87 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
HK$4.99 B 4,880.76% Jersey
Novavax
NVAX
HK$7.97 B 7,843.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
HK$1.12 M-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
HK$0.16 B 69.36%๐Ÿ‡ฌ๐Ÿ‡ง UK